Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 25

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
2 intermediate papers

Works of Martin van Cleeff being referenced

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
2016
Randomized, Controlled Trial of a 13-Valent Pneumococcal Conjugate Vaccine Administered Concomitantly with an Influenza Vaccine in Healthy Adults
2012

Author Peers

Author Last Decade Papers Cites
Martin van Cleeff 388 89 28 112 9 499
Janné Almeido-Hill 271 177 42 137 8 453
Anouk Oordt-Speets 270 138 22 180 13 451
Stéphane Grillet 271 48 17 126 17 434
José García-Sicilia 447 246 13 61 20 512
Hoang M. Phan 375 106 34 35 8 485
van Aken Wg 134 34 62 75 11 537
J. M. Stuart 374 327 15 67 10 455
A. M. Visintine 361 28 15 176 7 487
Malcolm Sperling 253 181 42 175 9 432
Jaclyn Bowman 287 95 73 45 7 465

All Works

Loading papers...

Rankless by CCL
2026